Relation between FIGO stage, primary tumor volume, and presence of lymph node metastases in cervical cancer patients referred for radiotherapy

被引:57
作者
Narayan, K [1 ]
Mckenzie, AF [1 ]
Hicks, RJ [1 ]
Fisher, R [1 ]
Bernshaw, D [1 ]
Bau, S [1 ]
机构
[1] Peter MacCallum Canc Inst, Div Radiat Oncol, Melbourne, Vic 8006, Australia
关键词
cervix cancer; lymph node; MRI; PET; radiotherapy; staging;
D O I
10.1046/j.1525-1438.2003.13026.x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The aims of this study were to determine, firstly, the relationship between FIGO stage and various tumor parameters determined by magnetic resonance imaging (MRI), and, secondly, whether any of these parameters were predictors of lymph node metastases as determined by fluorine-18 fluorodeoxyglucose positron emission tomography (FDG PET) in cervical cancer patients referred for radiotherapy. In 70 consecutive patients, both PET and MRI visualized all primary tumors except for one previously removed by cone biopsy. While clinical diameter and MRI-derived diameter showed a significant relationship between these two measurements (r = 0.70; P < 0.001) there was a large variability in MRI diameter for each FIGO stage and wide overlap. The average volume of primary cervical tumor on MRI was 60 cc (5-256). In FIGO stages, I, II, III and IV, uterine body involvement was present in 58%, 73%, 88%, and 100% of 19, 30, 16, and 5 patients, respectively (P-trend= 0.015). Node positivity on FDG PET was present in 11% of patients without uterine body extension, but increased to 75% in those with uterine involvement. Average tumor volume in node-negative patients was 49 cc (5-186). Average tumor volume in node-positive patients was 69 cc (8-256). There was a significant association between nodal involvement and both FIGO stage (P = 0.018) and uterine body involvement (P < 0.001), but tumor volume and longitudinal MRI diameter were not statistically significant in unifactor predictors of nodal involvement. In multivariate analysis only uterine body extension, however, was independently related to the risk of nodal involvement. In conclusion, MRI provides noninvasive tumor size evaluation and can also demonstrate invasion of the uterine body that appears to be associated with an increased risk of nodal metastasis. This may provide clinically important prognostic information not available from current FIGO staging.
引用
收藏
页码:657 / 663
页数:7
相关论文
共 30 条
  • [1] IDENTIFICATION OF PROGNOSTIC FACTORS AND RISK GROUPS IN PATIENTS FOUND TO HAVE NODAL METASTASIS AT THE TIME OF RADICAL HYSTERECTOMY FOR EARLY-STAGE SQUAMOUS CARCINOMA OF THE CERVIX
    ALVAREZ, RD
    SOONG, SJ
    KINNEY, WK
    REID, GC
    SCHRAY, MF
    PODRATZ, KC
    MORLEY, GW
    SHINGLETON, HM
    [J]. GYNECOLOGIC ONCOLOGY, 1989, 35 (02) : 130 - 135
  • [2] MAGNETIC-RESONANCE IMAGING IN CERVICAL-CANCER - A BASIS FOR OBJECTIVE CLASSIFICATION
    BURGHARDT, E
    HOFMANN, HMW
    EBNER, F
    HAAS, J
    TAMUSSINO, K
    JUSTICH, E
    [J]. GYNECOLOGIC ONCOLOGY, 1989, 33 (01) : 61 - 67
  • [3] PROGNOSTIC FACTORS AND OPERATIVE TREATMENT OF STAGE-IB TO STAGE-IIB CERVICAL-CANCER
    BURGHARDT, E
    PICKEL, H
    HAAS, J
    LAHOUSEN, M
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1987, 156 (04) : 988 - 996
  • [4] BURGHARDT E, 1992, CANCER, V70, P648, DOI 10.1002/1097-0142(19920801)70:3<648::AID-CNCR2820700318>3.0.CO
  • [5] 2-R
  • [6] PROSPECTIVE SURGICAL PATHOLOGICAL-STUDY OF DISEASE-FREE INTERVAL IN PATIENTS WITH STAGE IB SQUAMOUS-CELL CARCINOMA OF THE CERVIX - A GYNECOLOGIC ONCOLOGY GROUP-STUDY
    DELGADO, G
    BUNDY, B
    ZAINO, R
    SEVIN, BU
    CREASMAN, WT
    MAJOR, F
    [J]. GYNECOLOGIC ONCOLOGY, 1990, 38 (03) : 352 - 357
  • [7] THE INFLUENCE OF TUMOR SIZE AND MORPHOLOGY ON THE OUTCOME OF PATIENTS WITH FIGO STAGE IB SQUAMOUS-CELL CARCINOMA OF THE UTERINE CERVIX
    EIFEL, PJ
    MORRIS, M
    WHARTON, JT
    OSWALD, MJ
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1994, 29 (01): : 9 - 16
  • [8] Radical hysterectomy for stage IB1 vs IB2 carcinoma of the cervix: Does the new staging system predict morbidity and survival?
    Finan, MA
    DeCesare, S
    Fiorica, JV
    Chambers, R
    Hoffman, MS
    Kline, RC
    Roberts, WS
    Cavanagh, D
    [J]. GYNECOLOGIC ONCOLOGY, 1996, 62 (02) : 139 - 147
  • [9] SEVERE RADIATION MORBIDITY IN CARCINOMA OF THE CERVIX - IMPACT OF PRETHERAPY SURGICAL STAGING AND PREVIOUS SURGERY
    FINE, BA
    HEMPLING, RE
    PIVER, MS
    BAKER, TR
    MCAULEY, M
    DRISCOLL, D
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1995, 31 (04): : 717 - 723
  • [10] GADDUCCI A, 1995, ANTICANCER RES, V15, P1071